Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-03-01

Clinical Trial Update: Evaluation of Immunological Changes and Clinical Efficacy of Specific Immunotherapy With Der p House Dust Mite Allergen in Polysensitized and Monosensitized Patients With Allergic Rhinitis and/or Asthma.

View source ↗

Summary

A clinical trial update evaluating immunological changes and clinical efficacy of Der p house dust mite allergen immunotherapy in monosensitized and polysensiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Der p house dust mite allergen immunotherapy (house dust mite allergen (Dermatophagoides pteronyssinus) extract)

Snippet

Sponsor: Ankara University | Conditions: Allergen Immunotherapy, Immunological Mechanisms,Monosensitized,Polysensitized,Clinical Efficacy | Status: UNKNOWN